Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiangbin Wang

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
The Journal of Antimicrobial Chemotherapy|March 30, 2018
New single capsule of bismuth, metronidazole and tetracycline given with omeprazole versus quadruple therapy consisting of bismuth, omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a Chinese prospective, randomized, multicentre trialYong Xie, Xiaolin Pan, Yan Li, et al.
Journal of Viral Hepatitis|November 23, 2019
Peg-interferon and nucleos(t)ide analogue combination at inception of antiviral therapy improves both anti-HBV efficacy and long-term survival among HBV DNA-positive hepatocellular carcinoma patients after hepatectomy/ablationWenqian Qi, Qian Zhang, Yan Xu, et al.
Journal of Medical Virology|January 23, 2024
Association between NTCP hepatic expression and inflammation/fibrosis as well as gender-specific differences in chronic HBV-infected patientsJingyi Shi, Xu Wang, Wenqian Qi, et al.
Gastrointestinal Endoscopy|July 8, 2023
Comparison of the efficacy and safety of an oral sulfate solution and 3-L polyethylene glycol on bowel preparation before colonoscopy: a phase III multicenter randomized controlled trialPeng Pan, Shengbing Zhao, Shuling Wang, et al.
Journal of Gastroenterology and Hepatology|September 13, 2018
The efficacy of oral Zhizhu Kuanzhong, a traditional Chinese medicine, in patients with postprandial distress syndromeYinglian Xiao, Yuwen Li, Jianchang Shu, et al.
Helicobacter|July 24, 2018
Furazolidone-containing triple and quadruple eradication therapy for initial treatment for Helicobacter pylori infection: A multicenter randomized controlled trial in ChinaYong Xie, Zhenyu Zhang, Junbo Hong, et al.
Emerging Microbes & Infections|March 13, 2020
Long-term follow-up of <i>Helicobacter pylori</i> reinfection and its risk factors after initial eradication: a large-scale multicentre, prospective open cohort, observational studyYong Xie, Conghua Song, Hong Cheng, et al.
Frontiers in Medicine|August 2, 2021
Mucosal Healing Effectiveness and Safety of Anaprazole, a Novel PPI, vs. Rabeprazole in Patients With Duodenal Ulcers: A Randomized Double-Blinded Multicenter Phase II Clinical TrialXu Shu, Zhenhua Zhu, Yu Fu, et al.
Helicobacter|April 1, 2022
Diagnosis and treatment of Helicobacter pylori infection by physicians in China: A nationwide cross-sectional studyZhiqiang Song, Ye Chen, Hong Lu, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The Journal of Antimicrobial Chemotherapy|March 30, 2018
New single capsule of bismuth, metronidazole and tetracycline given with omeprazole versus quadruple therapy consisting of bismuth, omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a Chinese prospective, randomized, multicentre trialYong Xie, Xiaolin Pan, Yan Li, et al.
Journal of Viral Hepatitis|November 23, 2019
Peg-interferon and nucleos(t)ide analogue combination at inception of antiviral therapy improves both anti-HBV efficacy and long-term survival among HBV DNA-positive hepatocellular carcinoma patients after hepatectomy/ablationWenqian Qi, Qian Zhang, Yan Xu, et al.
Journal of Medical Virology|January 23, 2024
Association between NTCP hepatic expression and inflammation/fibrosis as well as gender-specific differences in chronic HBV-infected patientsJingyi Shi, Xu Wang, Wenqian Qi, et al.
Gastrointestinal Endoscopy|July 8, 2023
Comparison of the efficacy and safety of an oral sulfate solution and 3-L polyethylene glycol on bowel preparation before colonoscopy: a phase III multicenter randomized controlled trialPeng Pan, Shengbing Zhao, Shuling Wang, et al.
Journal of Gastroenterology and Hepatology|September 13, 2018
The efficacy of oral Zhizhu Kuanzhong, a traditional Chinese medicine, in patients with postprandial distress syndromeYinglian Xiao, Yuwen Li, Jianchang Shu, et al.
Helicobacter|July 24, 2018
Furazolidone-containing triple and quadruple eradication therapy for initial treatment for Helicobacter pylori infection: A multicenter randomized controlled trial in ChinaYong Xie, Zhenyu Zhang, Junbo Hong, et al.
Emerging Microbes & Infections|March 13, 2020
Long-term follow-up of <i>Helicobacter pylori</i> reinfection and its risk factors after initial eradication: a large-scale multicentre, prospective open cohort, observational studyYong Xie, Conghua Song, Hong Cheng, et al.
Frontiers in Medicine|August 2, 2021
Mucosal Healing Effectiveness and Safety of Anaprazole, a Novel PPI, vs. Rabeprazole in Patients With Duodenal Ulcers: A Randomized Double-Blinded Multicenter Phase II Clinical TrialXu Shu, Zhenhua Zhu, Yu Fu, et al.
Helicobacter|April 1, 2022
Diagnosis and treatment of Helicobacter pylori infection by physicians in China: A nationwide cross-sectional studyZhiqiang Song, Ye Chen, Hong Lu, et al.
Pageof 4